The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.

The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.

The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being ...

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...

O’Hara joins CMR’s executive team as commercial president and general manager for the U.S., following the FDA’s authorization ...

July and August have brought a steady beat of private financings for young medtech companies, with several deals supporting ...

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, ...

The president indicated that duties on chips would be “approximately 100%” earlier this month.

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.